Skip to main content

Advertisement

SpringerLink
Log in

What do we know about chronic renal failure in young adults? II. Adult outcome of pediatric renal disease

  • Review
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Congenital abnormalities of the kidney and urinary tract (CAKUT) account for more than half of all renal failure in children. For young adults with CAKUT two questions are paramount: what is the prognosis and what is the best management to improve outcome? The paediatric literature shows that prognostic factors are glomerular filtration rate (GFR) and the presence of proteinuria. We reviewed data from 101 young adult patients with either primary vesico-ureteric reflux and renal dysplasia or obstructive uropathy. Patients had an estimated GFR (eGFR) of ≤60 ml/min per 1.73 m2 body surface area and had had at least 5 years of follow up (median 162 months). There was a strong correlation between the amount of proteinuria at the start and overall rate of decline. Angiotensin-converting enzyme inhibitors (ACEIs) slowed declining renal function at all levels of function, but this only had a significant effect on renal outcome when eGFR was >35 ml/min. The ACEI benefit increased with time. Rate of decline was slower than reported for other diseases and was only −2.4 ml/min per year for those reaching the start of dialysis. Outcome is predictable by the level of residual renal function (GFR). Nevertheless, function remains stable while proteinuria is minimal. Short-term studies overestimate rates of deterioration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Neild GH (2009) What do we know about chronic renal failure in young adults? I. Primary renal disease. Pediatr Nephrol doi: s00467-008-1108-3

  2. Wingen AM, Fabian-Bach C, Schaefer F, Mehls O (1997) Randomised multicentre study of a low-protein diet on the progression of chronic renal failure in children. European Study Group of Nutritional Treatment of Chronic Renal Failure in Childhood. Lancet 349:1117–1123

    Article  CAS  PubMed  Google Scholar 

  3. Wuhl E, Mehls O, Schaefer F (2004) Antihypertensive and antiproteinuric efficacy of ramipril in children with chronic renal failure. Kidney Int 66:768–776

    Article  PubMed  Google Scholar 

  4. Ardissino G, Testa S, Dacco V, Vigano S, Taioli E, Claris-Appiani A, Procaccio M, Avolio L, Ciofani A, Dello SL, Montini G (2004) Proteinuria as a predictor of disease progression in children with hypodysplastic nephropathy. Data from the Ital Kid Project. Pediatr Nephrol 19:172–177

    Article  PubMed  Google Scholar 

  5. Ardissino G, Avolio L, Dacco V, Testa S, Marra G, Vigano S, Loi S, Caione P, De Castro R, De Pascale S, Marras E, Riccipetitoni G, Selvaggio G, Pedotti P, Claris-Appiani A, Ciofani A, Dello SL, Lama G, Montini G, Verrina E (2004) Long-term outcome of vesicoureteral reflux associated chronic renal failure in children. Data from the ItalKid Project. J Urol 172:305–310

    Article  PubMed  Google Scholar 

  6. Gonzalez Celedon C, Bitsori M, Tullus K (2007) Progression of chronic renal failure in children with dysplastic kidneys. Pediatr Nephrol 22:1014–1020

    Article  PubMed  Google Scholar 

  7. Smellie JM, Barratt TM, Chantler C, Gordon I, Prescod NP, Ransley PG, Woolf AS (2001) Medical versus surgical treatment in children with severe bilateral vesicoureteric reflux and bilateral nephropathy: a randomised trial. Lancet 357:1329–1333

    Article  CAS  PubMed  Google Scholar 

  8. Soares CM, Oliveira EA, Diniz JS, Lima EM, Vasconcelos MM, Oliveira GR (2003) Predictive factors of progression of chronic renal insufficiency: a multivariate analysis. Pediatr Nephrol 18:371–377

    PubMed  Google Scholar 

  9. Neild GH, Thomson G, Nitsch D, Woolfson RG, Connolly JO, Woodhouse CR (2004) Renal outcome in adults with renal insufficiency and irregular asymmetric kidneys. BMC Nephrol 5:12

    Article  PubMed  PubMed Central  Google Scholar 

  10. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F (2006) Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145:247–254

    Article  CAS  PubMed  Google Scholar 

  11. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD (1993) The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 329:1456–1462

    Article  CAS  PubMed  Google Scholar 

  12. The GISEN Group (1997) Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 349:1857–1863

    Article  Google Scholar 

  13. Maschio G, Alberti D, Janin G, Locatelli F, Mann JF, Motolese M, Ponticelli C, Ritz E, Zucchelli P (1996) Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N Engl J Med 334:939–945

    CAS  PubMed  Google Scholar 

  14. Zucchelli P, Gaggi R (1991) Reflux nephropathy in adults. Nephron 57:2–9

    Article  CAS  PubMed  Google Scholar 

  15. Nakashima Y, Matsuoka H, Oshima K, Sakamoto K (1997) Progression of renal disease in patients with reflux nephropathy. Follow-up study. Nippon Hinyokika Gakkai Zasshi 88:557–565

    CAS  PubMed  Google Scholar 

  16. Goodship TH, Stoddart JT, Martinek V, Geetha D, Brown AL, Ward MK, Kerr DN, Owen JP, Wilkinson R (2000) Long-term follow-up of patients presenting to adult nephrologists with chronic pyelonephritis and ‘normal’ renal function. QJM 93:799–803

    Article  CAS  PubMed  Google Scholar 

  17. Reinberg Y, de Castano I, Gonzalez R (1992) Prognosis for patients with prenatally diagnosed posterior urethral valves. J Urol 148:125–126

    Article  CAS  PubMed  Google Scholar 

  18. Drozdz D, Drozdz M, Gretz N, Mohring K, Mehls O, Scharer K (1998) Progression to end-stage renal disease in children with posterior urethral valves. Pediatr Nephrol 12:630–636

    Article  CAS  PubMed  Google Scholar 

  19. Kincaid-Smith P, Becker G (1978) Reflux nephropathy and chronic atrophic pyelonephritis: a review. J Infect Dis 138:774–780

    Article  CAS  PubMed  Google Scholar 

  20. Breyer JA, Bain RP, Evans JK, Nahman NS Jr, Lewis EJ, Cooper M, McGill J, Berl T (1996) Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy. The collaborative study group. Kidney Int 50:1651–1658

    Article  CAS  PubMed  Google Scholar 

  21. de Zeeuw D, Remuzzi G, Parving HH, Keane WF, Zhang Z, Shahinfar S, Snapinn S, Cooper ME, Mitch WE, Brenner BM (2004) Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL. Kidney Int 65:2309–2320

    Article  PubMed  Google Scholar 

  22. Peterson JC, Adler S, Burkart JM, Greene T, Hebert LA, Hunsicker LG, King AJ, Klahr S, Massry SG, Seifter JL (1995) Blood pressure control, proteinuria, and the progression of renal disease. The modification of diet in renal disease study. Ann Intern Med 123:754–762

    Article  CAS  PubMed  Google Scholar 

  23. Ruggenenti P, Perna A, Mosconi L, Matalone M, Pisoni R, Gaspari F, Remuzzi G (1997) Proteinuria predicts end-stage renal failure in non-diabetic chronic nephropathies. The “Gruppo Italiano di Studi Epidemiologici in Nefrologia” (GISEN). Kidney Int Suppl 63:S54–S57

    CAS  PubMed  Google Scholar 

  24. Parving HH, Andersen AR, Smidt UM, Hommel E, Mathiesen ER, Svendsen PA (1987) Effect of antihypertensive treatment on kidney function in diabetic nephropathy. BMJ 294:1443–1447

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Bjorck S, Mulec H, Johnsen SA, Norden G, Aurell M (1992) Renal protective effect of enalapril in diabetic nephropathy. BMJ 304:339–343

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Parving HH, Rossing P, Hommel E, Smidt UM (1995) Angiotensin-converting enzyme inhibition in diabetic nephropathy: ten years’ experience. Am J Kidney Dis 26:99–107

    Article  CAS  PubMed  Google Scholar 

  27. Barnett AH, Bain SC, Bouter P, Karlberg B, Madsbad S, Jervell J, Mustonen J (2004) Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy. N Engl J Med 351:1952–1961

    Article  CAS  PubMed  Google Scholar 

  28. Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, Striker G (1994) The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med 330:877–884

    Article  CAS  PubMed  Google Scholar 

  29. Levey AS, Greene T, Beck GJ, Caggiula AW, Kusek JW, Hunsicker LG, Klahr S (1999) Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study group. J Am Soc Nephrol 10:2426–2439

    CAS  PubMed  Google Scholar 

  30. Ruggenenti P, Perna A, Remuzzi G (2001) ACE inhibitors to prevent end-stage renal disease: when to start and why possibly never to stop: a post hoc analysis of the REIN trial results. J Am Soc Nephrol 12:2832–2837

    CAS  PubMed  Google Scholar 

  31. Ruggenenti P, Perna A, Loriga G, Ganeva M, Ene-Iordache B, Turturro M, Lesti M, Perticucci E, Chakarski IN, Leonardis D, Garini G, Sessa A, Basile C, Alpa M, Scanziani R, Sorba G, Zoccali C, Remuzzi G (2005) Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial. Lancet 365:939–946

    Article  PubMed  Google Scholar 

  32. Bjorck S, Nyberg G, Mulec H, Granerus G, Herlitz H, Aurell M (1986) Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. BMJ 293:471–474

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Ruggenenti P, Schieppati A, Remuzzi G (2001) Progression, remission, regression of chronic renal diseases. Lancet 357:1601–1608

    Article  CAS  PubMed  Google Scholar 

  34. Jafar TH, Stark PC, Schmid CH, Landa M, Maschio G, Marcantoni C, de Jong PE, de ZD, Shahinfar S, Ruggenenti P, Remuzzi G, Levey AS (2001) Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease. Kidney Int 60:1131–1140

    Article  CAS  PubMed  Google Scholar 

  35. Mogensen CE (1982) Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. BMJ 285:685–689

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Wilmer WA, Hebert LA, Lewis EJ, Rohde RD, Whittier F, Cattran D, Levey AS, Lewis JB, Spitalewitz S, Blumenthal S, Bain RP (1999) Remission of nephrotic syndrome in type 1 diabetes: long-term follow-up of patients in the Captopril Study. Am J Kidney Dis 34:308–314

    Article  CAS  PubMed  Google Scholar 

  37. Ruggenenti P, Perna A, Benini R, Bertani T, Zoccali C, Maggiore Q, Salvadori M, Remuzzi G (1999) In chronic nephropathies prolonged ACE inhibition can induce remission: dynamics of time-dependent changes in GFR. Investigators of the GISEN Group. Gruppo Italiano Studi Epidemiologici in Nefrologia. J Am Soc Nephrol 10:997–1006

    CAS  PubMed  Google Scholar 

  38. Ardissino G, Dacco V, Testa S, Bonaudo R, Claris-Appiani A, Taioli E, Marra G, Edefonti A, Sereni F (2003) Epidemiology of chronic renal failure in children: data from the ItalKid project. Pediatrics 111:e382–e387

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University College London (UCL) Centre for Nephrology, Royal Free Campus, London, NW3 2QG, UK

    Guy H. Neild

Authors
  1. Guy H. Neild
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Guy H. Neild.

Additional information

This article refers to the article that can be found at https://doi.org/10.1007/s00467-008-1108-3.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Neild, G.H. What do we know about chronic renal failure in young adults? II. Adult outcome of pediatric renal disease. Pediatr Nephrol 24, 1921–1928 (2009). https://doi.org/10.1007/s00467-008-1107-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-008-1107-4

Keywords

Search

Navigation